Abstract: A novel, selective, and sensitive reversed phase high-performance liquid chromatography (HPLC) method coupled with fluorescence detection has been developed for the determination of tobramycin (TOB) in pure form, in ophthalmic solution and in spikedhumanplasma.SinceTOBlacksUVabsorbingchromophoresandnativefluorescence,pre-columnderivatizationofTOBwas carriedoutusingfluorescaminereagent(0.01%,1.5mL)andboratebuffer(pH8.5,2mL).Experimentaldesignwasappliedforoptimizationofthederivatizationstep.Theresultinghighlyfluorescentstable derivative was chromatographed on C 18 column and eluted usingmethanol:water(60:40,v/v)ataflowrateof1mLmin .Afluorescencedetector(λ ex 390andλ em 480nm)wasused.Themethod waslinearovertheconcentrationrange20-200ngmL −1 .Thestructureofthefluorescentproductwasproposed,themethodwasthen validatedandappliedforthedeterminationofTOBinhumanplasma.Theresultswerestatisticallycomparedwiththereferencemethod, revealingnosignificantdifference.
Introduction
Tobramycin (TOB, Fig. 1 ) is an aminoglycoside antibiotic produced by Streptomyces tenebrarius. It exhibits a broad spectrum activity against aerobic gram-negative bacteria, particularly Pseudomonas aeruginosa,whichmakesittheantibioticofchoicein the treatment of pulmonary infections.
1,2 ThebactericidalactivityofTOB isaccomplishedby inhibiting ribosomal function leading to interruption in bacterial protein synthesis. 3 It is used topically for treatment of eye infections, parenterally for treatment of seriousbacterialinfection,andalsoforlocalapplication in the oral cavity and stomach as part of selective decontamination of the digestive tract. 1, 4 Like other aminoglycosides, the use of TOB can create potentialdose-relatedsideeffectsofototoxicityand nephrotoxicity. Even though it is poorly absorbed, prolongedoraladministrationcanproducesuchtoxic effects. 3 Therefore, careful monitoring of the drug levelinplasmaisrequiredfortherapeuticandtoxic control, especially when therapy is of long duration.
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Several analytical techniques were reported for the analysisofTOBindosageformsandinbiologicalfluids including spectrophotometry, [6] [7] [8] [9] spectrofluorimetry, 6, 7, 10 capillary electrophoresis, 11 andTLCdensitometry. 12, 13 A number of high-performance liquid chromatography (HPLC) methods were described using specific detection modes such as evaporative light scattering detection, 14, 15 pulsed electrochemical detector, and tandem mass spectrometry. [16] [17] [18] Chemically, TOB consists of amino sugars linked glycosidically with 1,3-diaminocyclohexanecentralring. 19 Like most carbohydrates, TOB lacks UV absorbing chromophores and does not possess native fluorescence, leading to a major challenge in the analysis of such a compound due to problematic detection. 20 Therefore, derivatization with a suitable absorbance-enhancing or fluorescence-producing agent is required for the detection by chromatographic techniques. HPLC methods with fluorescence detection, after derivatization 21 or indirect fluorescence detection, based on ligand displacement 22 were previously employed. However, most of these techniques have various limitations, for example, the useof2,4,6-trinitrobenzenesulfonicacid 23 and1-fluro-2,4-dinitrobenzene 24 aspre-columnderivatizingagents is undesirable due to their high toxicity. The main disadvantages of 2,4-dinitrofluorobenzene reagent, employed by USP, 25 and fluorescein isothiocyanate 21 were the length of time and the temperature required to achievethereaction.O-phthalaldehyde,usedinpostcolumnderivatization,ledtotheformationofaderivativewithpoorstability. 26 Therefore,theobjectivesof thisworkweretoemployanontoxicderivatizingagent and to enhance the formation of a more stablefluorescent derivative while maintaining high sensitivity.
Fluorescamine reagent is a useful derivatizing reagent that reacts with primary amino group to form fluorescentpyrrolinonemoieties. 27 Optimizationofthe pre-column derivatization step was performed using DesignofExperiments(DOE)approach.Thechemometricapproachrequiresarelativelylimitednumber ofexperimentstodefinethefactorswhichaffectthe derivatizationreactionandtoobtaintheoptimumconditionsfortheformationoffluorescentderivative. 28, 29 Thismanuscriptdescribesthedevelopmentofanew HPLCmethodcoupledwithfluorescencedetectionfor the analysis of TOB after pre-column derivatization. Thevalidatedmethodwasappliedforthedetermination ofTOBineyedropsandinspikedhumanplasma.
experimental Instrumentation
All fluorescence measurements were carried out using a Shimadzu RF-1501 Spectrofluorophotometer (Shimadzu Corporation, Kyoto, Japan), with excitation and emission band pass of 5 nm using 1 cm quartz cell. Experimental matrices, three dimensional (3D) surface plots, and contour curvesweregeneratedusingMinitab(Version15) statistical software (State College, Pennsylvania, USA). The chromatographic system was composedofasolventdelivery(LC-10AD,Shimadzu, Japan), a system controller model CBM-20A Communications BUS module and a spectrofluorometric detector (RF-551) with excitation and emission wavelengths set at 390 nm and 480 nm, respectively. Separation was achieved on Waters C 18 column(250×4.6mm,i.d.)packedwith5µm particle size (USA). The mobile phase was composedofmethanol:water(60:40,v/v)andpumped at1mLmin −1 flowrate.Themobilephasewasfiltered through 0.45 µm membrane filter (Sartorius Stedim Biotech GmbH, Germany) and degassed before use.All the work was carried out at room temperature, at Center of Applied Research and AdvancedStudy(CARAS)inFacultyofPharmacy, CairoUniversity. 
Materials and reagents
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Construction of calibration graph
AliquotsofTOBsulfateworkingstandardsolutioncontainingafinaldrugconcentrationof20-200ngmL
weretransferredintoaseriesof10mLvolumetricflasks. Toeachflask,2mLofboratebufferwithpH8.5were addedfollowedby1.5mLofFLreagent(0.01%w/v). Eachsolutionwasshakenfor5minutesandthenfilled to flask volume with distilled water. After standing for15minutes,20µL portions of each solution were injected in three replicates into the chromatograph. Theeluentsweredetectedbythefluorescencedetector withthewavelengthofexcitationfixedat390nmand thatofemissionfixedat480nm.Thesignalsemerging from the detector were integrated as peak area and a calibration graph was obtained by plotting the peaks areasagainstthecorrespondingconcentrationsofTOB sulfate and the regression equation was computed.
Analysis of pharmaceutical dosage form
SamplesolutionofTOBwaspreparedataconcentrationof1.2µg mL −1 bydiluting1mLofTobrin ® eye drops(equivalentto3mgTOBbase)to25mLwith distilled water, then diluting 1 mL of the resulting solutionto100mLwiththesamesolvent.Different aliquotsoftheobtainedsolutionwereanalyzedusing the procedure mentioned in the section "Construction ofcalibrationgraph."
Procedure for spiked human plasma
Aliquots of drug free human plasma (1 mL) were transferredintoaseriesofcentrifugetubesandspiked with differentconcentrationsofTOBsulfatestandard solution.Acetonitrile (2 mL) was then added to each tube to precipitate the plasma proteins. The samples weremixedbyverticalagitation(2minutes)usingvortexapparatusandcentrifugedat3000rpmfor5 minutes. Theresultingsupernatantwastransferredintoaclean glass tube and evaporated to dryness in a water bath (40°C).Theresidueobtainedwasreconstitutedindistilled water (1 mL) and the obtained solutions were analyzed using the procedure mentioned in section "Constructionofcalibrationgraph."Theareaunderthe peak, arising at a retention time 3 ±0.1minutes,was recorded and the concentration of the drug in plasma wasdeterminedbyusingtheregressionequation.
Determination of the stoichiometry of the reaction
Based on the optimumexperimental conditions,the stoichiometryofthereactionwasstudiedbyadopting the limiting logarithmic method. 33 Log of the molar concentration of fluorescamine was plotted versus logofthefluorescenceintensityusingconstantconcentration of TOB. Additionally, log of the molar concentrationofTOBwasplottedversuslogofthe fluorescence intensity using constant concentration offluorescamine.Theslopesofthetwostraightlines obtainedweremeasured.
Results and Discussion
TOB structure is characterized by the presence of saturated ring system that does not exhibit any significant absorption in the UV and visible region. The very low absorptivity of TOB does not permit its direct quantification at low concentrations, particularly if there is need to estimate the drug in plasmaorinbiologicalfluids. 20 Thisproblemcould besolvedbyderivatizingthecompoundbyasuitable fluorogenic reagent. Fluorescamine offers enhanced fluorescencedetectionofprimaryamine. 27 It has no inherent fluorescent property and is quickly hydrolyzed in water. Additionally, degradation products are non-fluorescent. Therefore, the fluorescence of the solution containing amines and fluorescamine is proportional to the quantity of free amine groups present.Fluorescamineiswidelyusedasaderivatizing reagent for the determination of many drugs, such asamoxicillin 34 and oseltamivir. 35 SinceTOBcontains primaryaliphaticaminogroup,itreactedwithfluorescamine in alkaline medium, at room temperature. The condensation reaction was complete in a few minutesandformedahighlyfluorescentpyrrolinone derivative. The formed stable fluorescent derivative of TOB was quantified in ophthalmic solution and spiked human plasma using HPLC method coupled withfluorescencedetection.
Optimization of the pre-column derivatization reaction conditions
Thetraditionalmethodperformedforoptimizationof reactionconditionswasbasedonchangingonevariableatatime(OVATapproach)whichdidnotdepict thecombinedeffectsofallthevariablesinvolvedin the reaction. 29 Therefore, experimental design using FCC design was applied to facilitate method developmentbyvaryingallthefactorstogether.FCCdesign has distinct advantages, such as the use of minimum numberofexperimentsandfeasibilityofgenerating datathatcanbeanalyzedstatisticallytoprovidevaluable information on the interactions among experimental parameters.
Scanning of the excitation and emission spectra of the reaction product of fluorescamine with TOB showed that optimal excitation and emission wavelengthswere390nmand480nm,respectively (Fig.2) .Distilledwaterwasthesolventofchoicefor thedrugasalcoholswerefoundtoreactwithfluorescamine to form additional products that could drastically reduce the reactivity of the reagent toward primary amines. 36 Borate buffer was found to be suitable as it contains no primary amines. The factorsselectedfor considerationwere bufferpH (X 1 ), volumeofboratebuffer(X 2 ),andvolumeoffluorescaminereagent(X 3 ).
The FCC design was applied and twenty experiments were conducted using the levels described in Table1.Thecoefficientsofthesecond-orderpolynomial model were computed and the following equation was deduced: 
WhereYisthefluorescenceintensity;andX 1 ,X 2 and X 3 are buffer pH, volume of buffer and volume of fluorescaminereagent,respectively. Fromthevaluesobtainedfortheparametersinthe FCC design ( Table 2) , it could be established that thefluorescenceintensityisdirectlyrelatedtoallthe three factors. Two of the factors have significant influenceontheresponse,bufferpH,andvolumeof fluorescaminereagent(P ,0.05)whichsignificantly increases the fluorescence intensity when they are increased. However, the significant quadratic term ( X 1 2 , P = 0.024) indicates non-linear correlation between the factor and the response, as revealed in the interaction plots (Fig. 3) .The individual effects ofbufferpHandvolumeoffluorescaminearepositive while their quadratic effects are negative, thus indicating that the fluorescence intensity increases with increase of the factor up to a critical threshold after which a further increase results in a decrease in the response (level 0 of X 1 and level 1 of X 3 were chosen).Inaddition,theinteractionbetweenthethree factorsisnotsignificant(P .0.05).
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Pareto charts (Fig.4 )revealthatthefactorswhich werestatisticallysignificant(P ,0.05)arebufferpH andvolumeoffluorescamine,confirmingtheresults deducedfromthepolynomialequation(2).
graphical evaluation, residual and statistical analysis of FCC design Three dimensional response surface plots and two dimensionalcontourplots,keepingoneofthevariables at the central point, are presented in Figure5.From these plots, optimal conditions for the pre-column derivatization reaction were derived. The highest fluorescenceintensitywasobtaineduponusing2mL ofboratebufferpH8.5and1.5mLoffluorescamine (0.01%w/vinacetone).Contourplotsshowedcurvature, indicating the non-linear effects of these factors onfluorescenceintensity. 28 Close inspection of Figure 6A reveals that the residuals fall on a straight line, indicating that the errors arenormallydistributed.Histogramoftheresiduals is bell-shaped indicating the absence of skewness and outliers (Fig.6B) .Theplotsofresidualsversus fits and versus order ( Fig. 6C and D) show that no obvious pattern appeared. An almost equal scatter aboveandbelowtheX-axiscanbeobserved,implyingtheabsenceofnon-constantvarianceandthatthe proposed model is adequate.
29
ANOVA analysis of the model reveals that the modelissignificant,thatis,atleastoneoftheterms in the regression equation (linear and quadratic terms) makes a significant impact on the mean response ( Table 3) .A non significant lack of fit (P = 0.067) indicates that the model fits the data well and can beusedtopredictthefluorescenceintensityofTOB withinthelimitsoftheexperiment. 29 Finally, the reaction was complete after shaking for15minutesandtheproductremainedstable for at least 3 hours.
Stoichiometry and mechanism of the reaction
By applying the liming logarithm method, 33 two straightlineswereobtainedwithslopevaluesof0.41 and0.45 (Fig.7A) .Bydividingtheslopesofthetwo lines,avalueof1.09wasobtained.Itwas therefore concluded that the reaction proceeds in a molar ratio of 1:1. This could be attributed to the decreased basicityoftheaminogroupbyitsvicinalhydroxyl groups, leaving only one amino group (NH 2 *) withenoughbasicitytoreactwith fluorescamine. Based upon these facts and the previous reported studies, 27 the reaction pathway between TOB and fluorescamine could be represented as shown in Figure7B.
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Development of the chromatographic method
A variety of mobile phases were investigated in the development of the HPLC-fluorescence detection method for the analysis ofTOB.The suitability of mobile phase was decided on the basis of assay sensitivity, suitable retention time, and peak shape. A mobile phase consisting of methanol:water in differentratioswasfirsttried.Itwasfoundthatincreasing the volume of water helped to sharpen the peak of TOB. Replacing methanol with acetonitrile distorted thepeakshapewithnosignificantchangeinretention time. A mobile phase composed of methanol:water (60:40,v/v)ataflowrateof1mLmin −1 gave sharp peak of TOB at a retention time of 3 ± 0.1 minutes (Fig.8A) .
Upon optimization of the factors affecting the fluorescence intensity in the pre-column derivatiza-Linearity and range Linearity was evaluated by linear regression analysis. A linear relationship between the peak areas and the corresponding concentrations was demonstrated by a good correlation coefficient obtainedfortheregressionline(0.9990),acrossthe concentrationrange20-200ngmL −1 . Data from the regression line was used to provide mathematical estimation of the degree of linearity. Parameters for the analytical performance of the proposed method and descriptive statistics of the regression line were revealed in Table4.
Accuracy
Accuracy of the suggested method was evaluated by replicate analysis and recovery determination of pure samples of TOB covering the linearity range (Table5).Theresultsobtainedwerecomparedwith those obtained using the reference spectrophotometric method.
30 Statistical analysis, using student's t-test and variance ratio F-test, revealed no significantdifferencebetweentheproposedmethodandthe reported one with respect to accuracy and precision (Table 6) .
Furthermore, the validity of the suggested method was evaluated by applying the standard addition technique. Recovery results suggest that themethodwasunaffectedbythepresenceofformulation excipients and confirm high accuracy (Table 7) . Precision Table4summarizestheresultsofthedetermination of intraday and interday assay precision. The intraday assay precision of the method, based on within tion step and that of the chromatographic procedure, the suggested method was applied successfully to the determinationofTOBinpureform,bothineyedrops and in spiked human plasma.
Method validation
The optimized chromatographic method was validated according to the International Conference on Harmonization(ICH)Q2(R1)guidelines. 
Specificity
The method was developed to demonstrate the discrimination of the analyte in the presence of excipients in a pharmaceutical product and in human plasma.Specificitywasindicatedbytheabsenceof any interference at the retention time of the peak of interest as evaluated by comparing the chromatograms of TOB pure sample, tobrin ® eye drops, and plasmaspikedwithTOB.Figure8indicatesthatthe suggestedmethodwashighlyspecificfortheanalysis ofTOB.
Limit of detection and limit of quantification AccordingtoICHQ2B,thelimitofdetection(LOD) andlimitofquantification(LOQ)weredeterminedby establishingtheminimumlevelatwhichtheanalyte canbereliablydetectedandthelowestconcentration that can be measured, respectively. LOD and LOQ were calculated as 3.3 ×SD/slopeand10×SD/slope, respectively, where SD is the standard deviation of the response (Table4).
System suitability
The system suitability test was performed according to the USP 25 in order to check parameters such as tailing factor, number of theoretical plates and height equivalent to theoretical plate (HETP) (Table4).
Analysis of TOB in spiked human plasma
Thehighsensitivityoftheproposedmethodallowed the determination of TOB in human plasma. To avoid loss of analyte due to clean-up procedures and increase its recovery, the number of clean-up steps inasamplepreparationprocedureshouldbekeptto a minimum. Protein precipitation is commonly used forfastsampleclean-upanddisruptingprotein-drug binding.Inthepresentmethod,acetonitrilewaschosen as the protein precipitant as it resulted in good signalintensities,highextractionrecoveriesforTOB, and relatively clean chromatograms under fluorescence detection 40 (Fig. 8b) . Satisfactory results were obtained(Table5).
conclusion
A sensitive, precise, and accurate method based on HPLCcoupledwithfluorescencedetectionhasbeen developed for the analysis of TOB in pure sample, eye drops, and spiked human plasma. Experimental design was successfully applied for optimization of the pre-column derivatization reaction, saving time, and cost. The method was successfully validated for linearity, accuracy, precision, and specificity. It offers several advantages including the use of non toxic derivatizing reagent and high sensitivity. In addition,specificitywasevidentfromtheanalysisof TOB in pharmaceutical dosage form and in spiked humanplasmawithnointerferencefromexcipients. The extraction procedure, using deproteinization of plasma samples, was simple and the recovery was morethan95%.Therefore,theproposedmethodwas foundtobesuitable for routine analysis of the drug in qualitycontrollaboratories. 
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